Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or in ammation in patients with atherosclerosis and type 2 diabetes.
Authors: Malgorzata Poreba, Magdalena Mostowik, Aleksander Siniarski, Renata Golebiowska‐Wiatrak, Krzysztof Piotr Malinowski, Maciej Haberka, Ewa Konduracka, Jadwiga Nessler1, Anetta Undas, Grzegorz Gajos
Published in: Cardiovascular Diabetology
Publication type: article
Subject areas: Medicine
SJR best quartile: Q1